DUBLIN, Ohio, April
7, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) Specialty
Solutions today launched Cardinal Health™ Navista™ Tech Solutions
(TS), an advanced suite of technology solutions to help community
oncologists improve outcomes and costs associated with patient
treatment as they transition to value-based care.
"Community-based oncology practices are facing unprecedented
pressure as they pivot to adapt to value-based reimbursement
models," said Heidi Hunter,
President of Cardinal Health Specialty Solutions. "With Navista™
TS, we are delivering the most complete set of integrated,
AI-enabled solutions and actionable insights to enable oncologists
to improve patient care and enhance practice performance."
Navista™ TS is comprised of connected, point-of-service
technology solutions including:
- Episode Analytics, a data-driven cost tracking tool,
developed by Cardinal Health's innovation engine,
Fuse. This tool enables oncologists and administrators to
accurately measure the cost of care at the start of and during the
episode of care, allowing for more informed treatment decisions and
clearer insights into value-based performance.
- CureMD Oncology Cloud. The integrated platform
includes electronic health records (EHR), a practice management
system (PMS), revenue cycle management services (RCM), a patient
portal and telehealth solutions. The platform helps to simplify
decision making, streamline operations and ensure a smooth
transition to value-based care, saving providers time and reducing
administrative burden so they can focus on patient care. CureMD and
Cardinal Health will work collaboratively to provide CureMD's
oncology tech solutions.
- AI-enabled population health decision support, CORE™, by
Jvion. CORE™ helps oncologists to proactively identify patients
who are at, or on an accelerated path to becoming, high-risk of
adverse events. The CORE surfaces the clinical and socioeconomic
levers and interventions to deploy to avoid costly ER and hospital
visits. Cardinal Health is the exclusive reseller of Jvion oncology
products to community oncology practices.
- Clinical trials matching solution, VIPER™, by Deep
Lens. VIPER™ uses AI to identify and match cancer patients
to clinical trials, including precision medicine studies, faster
and more efficiently. Cardinal Health and Deep Lens are working in
collaboration to deliver VIPER™ to community oncology
practices.
Through this comprehensive suite of solutions, Navista™ TS helps
oncology practices understand the biggest cost and value drivers,
identify treatments that offer the highest-quality care at the
lowest cost, and select the right care plan at the onset of
treatment. It also helps to automate manual processes and reduce
administrative burdens.
Navista™ TS may be used together as an integrated suite or as
standalone tools. For more information, visit
www.cardinalhealth.com/navista.
About Cardinal Health
Cardinal Health is a
distributor of pharmaceuticals, a global manufacturer and
distributor of medical and laboratory products, and a provider of
performance and data solutions for health care facilities. With 50
years in business, operations in more than 40 countries and
approximately 48,000 employees globally, Cardinal Health is
essential to care. Information about Cardinal Health is available
at cardinalhealth.com.
Contacts
Marcia
Frederick, marcia.frederick@cardinalhealth.com and (614)
757-9968; Investors: Kevin Moran,
kevin.moran@cardinalhealth.com and (614) 757-7942.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cardinal-health-launches-navista-ts-to-help-oncology-practices-improve-patient-care-lower-costs-and-drive-success-in-value-based-care-301264044.html
SOURCE Cardinal Health